HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Pre-IPO Transwarp Technology (PHIP Updates) - Some Points Worth the Attention

Pre-IPO Shenzhen Longsys Electronics (PHIP Updates) - Some Points Worth the Attention

Pre-IPO Ligent Technologies (PHIP Updates) - Some Points Worth the Attention

Pre-IPO Easy Click Worldwide Network Technology (A/H Listing) - About the Business and the Outlook

Pre-IPO Chongqing Afari Technology (A/H Listing) - The Business Model and the Concerns Behind

Pre-IPO Verisilicon Microelectronics (A/H Listing)-Difficulty Breaking Through Competitors' Barriers

Equity Capital Markets

Guangdong Topstar Technolo-A / Equity Capital Markets

<ul>
<li>Strategic transformation is crucial for understanding Topstar's business model. However, new business requires continuous capital expenditure and shows no signs of return in short term, further exacerbating the profit pressure.</li>
<li>The logic of Topstar's business model is a "scenario+ robot+ data+ AI" business loop, with deep connection with 3C industry, but if demand in consumer electronics declines, performance will fluctuate.</li>
<li>The Hong Kong stock market is relatively rational. Emerging industry companies may not necessarily receive high valuations. We think based on 2026 forecast, comfortable valuation could be P/E of 50-80x.</li>
</ul>


Strategic transformation is crucial for understanding Topstar's business model. However, new business requires continuous capital expenditure and shows no signs of return in short term, further exacerbating the profit pressure.
The logic of Topstar's business model is a "scenario+ robot+ data+ AI" business loop, with deep connection with 3C industry, but if demand in consumer electronics declines, performance will fluctuate.
The Hong Kong stock market is relatively rational. Emerging industry companies may not necessarily receive high valuations. We think based on 2026 forecast, comfortable valuation could be P/E of 50-80x.


Pre-IPO Guangdong Topstar Technology (A/H Listing) - Deep Dive the Business Model, Concerns, Outlook